Human epidermal growth factor receptor 2-positive (HER2+) breast cancer is characterized by amplification and/or overexpression of HER2 and is defined as HER2 immunohistochemistry (IHC) 3+ or IHC 2+/in situ hybridization (ISH)-amplified [2]. The gene discussed is ERBB2; the disease is breast carcinoma.